BDX vs CYCN · P/E 34, rev $21.84B vs $8.6M cap
Becton Dickinson and Company (BDX) versus Cyclerion Therapeutics Inc (CYCN) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Cyclerion Therapeutics Inc (CYCN) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported CYCN revenue for 2026-06-30 was $0. Net income was -$4.9M. CYCN currently screens at market cap $8.6M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. CYCN currently screens at market cap $8.6M.
Not investment advice. Open the BDX and CYCN stock pages for the full models.
Not investment advice.